Véronique Pons

Véronique Pons

Auto-generated profile, based on publicly available information

Véronique Pons

INSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université de Toulouse, France

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2005 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
IBIsabelle Le Blanc
Isabelle Le Blanc
PLPierre-Philippe Luyet
Pierre-Philippe Luyet
VPVéronique Pons
Véronique Pons
CFCharles Ferguson
Charles Ferguson
NENeil Emans
Neil Emans
JGJ. Gruenberg
J. Gruenberg
During viral infection, fusion of the viral envelope with endosomal membranes and nucleocapsid release were thought to be concomitant events. We show here that for the vesicular stomatitis virus they occur sequentially, at two successive steps of the endocytic pathway. Fusion already occurs in transport intermediates between early and late endosomes, presumably releasing the nucleocapsid within the lumen of intra-endosomal vesicles, where it remains hidden. Transport to late endosomes is then required for the nucleocapsid to be delivered to the cytoplasm. This last step, which initiates infection, depends on the late endosomal lipid lysobisphosphatidic acid (LBPA) and its putative effector Alix/AIP1, and is regulated by phosphatidylinositol-3-phosphate (PtdIns(3)P) signalling via the PtdIns(3)P-binding protein Snx16. We conclude that the nucleocapsid is exported into the cytoplasm after the back-fusion of internal vesicles with the limiting membrane of late endosomes, and that this process is controlled by the phospholipids LBPA and PtdIns(3)P and their effectors.

23 February 2015 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
MBMorgane Bellot
Morgane Bellot
SGSégolène Galandrin
Ségolène Galandrin
CBCédric Boularan
Cédric Boularan
HMHeinrich J Matthies
Heinrich J Matthies
FDFabien Despas
Fabien Despas
CGCéline Galés
Céline Galés

20 September 2011 in Science Signaling
Verified
Journal Article
Closed access
PDF file
DRDamien Ramel
Damien Ramel
FLFrédéric Lagarrigue
Frédéric Lagarrigue
VPVéronique Pons
Véronique Pons
JMJoëlle Mounier
Joëlle Mounier
SDSophie Dupuis-Coronas
Sophie Dupuis-Coronas
BPBernard Payrastre
Bernard Payrastre
Shigella keeps infected cells alive by preventing the lysosomal trafficking and degradation of an activated growth factor receptor.

19 August 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
AFAurélie C. Fabre
Aurélie C. Fabre
CMCamille Malaval
Camille Malaval
AAAbduelhakem Ben Addi
Abduelhakem Ben Addi
CVCéline Verdier
Céline Verdier
VPVéronique Pons
Véronique Pons
LMLaurent O. Martínez
Laurent O. Martínez
A major atheroprotective functionality of high-density lipoproteins (HDLs) is to promote “reverse cholesterol transport” (RCT). In this process, HDLs mediate the efflux and transport of cholesterol from peripheral cells and its subsequent transport to the liver for further metabolism and biliary excretion. We have previously demonstrated in cultured hepatocytes that P2Y13 (purinergic receptor P2Y, G protein–coupled, 13) activation is essential for HDL uptake but the potential of P2Y13 as a target to promote RCT has not been documented. Here, we show that P2Y13-deficient mice exhibited a decrease in hepatic HDL cholesterol uptake, hepatic cholesterol content, and biliary cholesterol output, although their plasma HDL and other lipid levels were normal. These changes translated into a substantial decrease in the rate of macrophage-to-feces RCT. Therefore, hallmark features of RCT are impaired in P2Y13-deficient mice. Furthermore, cangrelor, a partial agonist of P2Y13, stimulated hepatic HDL uptake and biliary lipid secretions in normal mice and in mice with a targeted deletion of scavenger receptor class B type I (SR-BI) in liver (hypomSR-BI–knockoutliver) but had no effect in P2Y13 knockout mice, which indicate that P2Y13-mediated HDL uptake pathway is independent of SR-BI–mediated HDL selective cholesteryl ester uptake. Conclusion: These results establish P2Y13 as an attractive novel target for modulating RCT and support the emerging view that steady-state plasma HDL levels do not necessarily reflect the capacity of HDL to promote RCT. (Hepatology 2010)

2 September 2008 in PLOS Biology
Verified
Journal Article
Open access
PDF file
VPVéronique Pons
Véronique Pons
PLPierre-Philippe Luyet
Pierre-Philippe Luyet
EMEtienne Morel
Etienne Morel
LALaurence Abrami
Laurence Abrami
GGGisou Van Der Goot
Gisou Van Der Goot
JGJean Gruenberg
Jean Gruenberg
After internalization, ubiquitinated signaling receptors are delivered to early endosomes. There, they are sorted and incorporated into the intralumenal invaginations of nascent multivesicular bodies, which function as transport intermediates to late endosomes. Receptor sorting is achieved by Hrs—an adaptor-like protein that binds membrane PtdIns3P via a FYVE motif—and then by ESCRT complexes, which presumably also mediate the invagination process. Eventually, intralumenal vesicles are delivered to lysosomes, leading to the notion that EGF receptor sorting into multivesicular bodies mediates lysosomal targeting. Here, we report that Hrs is essential for lysosomal targeting but dispensable for multivesicular body biogenesis and transport to late endosomes. By contrast, we find that the PtdIns3P-binding protein SNX3 is required for multivesicular body formation, but not for EGF receptor degradation. PtdIns3P thus controls the complementary functions of Hrs and SNX3 in sorting and multivesicular body biogenesis. The cell's genetic program is modulated by extracellular signals that activate cell surface receptors and, in turn, intracellular effectors, to regulate transcription. For cells to function normally, these signals must be turned off to avoid permanent activation—a situation often associated with cancer. For many receptors, signaling is repressed, or down-regulated, in a process that first internalizes and then degrades the receptors. After receptors are removed from the cell surface into structures called early endosomes, they are selectively incorporated within vesicles that form inside the endosome. During this process, endosomal membranes are pulled away from the cytoplasm towards the endosome lumen, against the flow of intracellular membrane traffic, eventually resulting in the formation of a “multivesicular body” (vesicles within vesicles). The common view is that these intralumenal vesicles are then delivered to lysosomes, where they are degraded along with their receptor cargo. We have investigated the mechanisms responsible for the biogenesis of intralumenal vesicles in multivesicular bodies. We find that the small protein SNX3, which binds the signaling lipid phosphatidyl inositol-3-phosphate, is necessary for the formation of intralumenal vesicles, but is not involved in the degradation of the cell surface receptor for EGF. Conversely, we find that Hrs, which also binds phosphatidyl inositol-3-phosphate and mediates receptor sorting into intralumenal vesicles, is essential for lysosomal targeting but dispensable for multivesicular body biogenesis. Phosphatidyl inositol-3-phosphate thus controls the complementary functions of Hrs and SNX3 in the sorting of signaling receptors and multivesicular body biogenesis.

20 November 2008 in Traffic
Verified
Journal Article
Closed access
PDF file
PLPierre‐Philippe Luyet
Pierre‐Philippe Luyet
Thomas FalguièresThomas Falguières
Thomas Falguières
VPVéronique Pons
Véronique Pons
Asit PattnaikAsit Pattnaik
Asit Pattnaik
JGJean Gruenberg
Jean Gruenberg